Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac plus paracetamol versus morphine for acute flank pain due to kidney colic
IRCT20220108053669N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketorolac, acetaminophen and morphine in nephrolithiasis (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Analgesic effect. Started Jan 2022; status: completed.
02
Drugs
ketorolacacetaminophenmorphine
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20220108053669N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220108053669N1.